Table 2

Loss of T cell antigens and T cell receptor γ (TCR-γ) gene clonality in patients with enteropathy-type intestinal T cell lymphoma (EITCL), without EITCL, and in refractory sprue (RS)

Loss of CD82-150 Loss of TCR-β2-152 Loss of CD8
or TCR-β 		Clonality of the TCR-γ gene Loss of CD8/TCR-β or clonality of the TCR-γ gene
EITCL group (n=13)2-151 8  (62%)13  (100%)11  (85%)7  (54%)13  (100%)
 EITCL (n=8)4 (50%)6 (100%)2-151 7 (87.5%)3 (37.5%)7 (87.5%)
 UJ (n=2)2 (100%)2 (100%)2 (100%)2 (100%)2 (100%)
 RS-Tu (n=3)2 (67%)3 (100%)3 (100%)2 (67%)3 (100%)
Non-EITCL (n=13)3 (23%)3 (23%)4 (31%)04 (31%)
 CD (n=8)1 (12.5%)01 (12.5%)01 (12.5%)
 RSDD (n=5)2 (40%)3 (60%)4 (80%)04 (80%)
RS (n=6)2 (33%)3 (50%)4 (67%)1 (17%)4 (67%)

  • ↵2-151 TCR-β was evaluated in only 11 patients in the EITCL group.

  • ↵2-150 Less than 50% of IELs positive for CD8.

  • ↵2-152 Less than 50% of IELs positive for TCR-β.

  • For further abbreviations, see table 1.